僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Dinutuximab （Unituxin; APN-311） is a chimeric, human-murine, anti-GD2 monoclonal antibody. Dinutuximab potently enlongs event-free survival and overall survival, in high-risk neuroblastoma treatment, in combination with granulocyte-macrophage colony-stimulating factor （GM-CSF）, aldesleukin （interleukin-2 [IL-2]）, and isotretinoin （13-cis-retinoic acid [RA]）